Market Segmentation:
- By Product Type
- Mechanical Thrombectomy Devices
- Aspiration Thrombectomy Devices
- Hybrid Thrombectomy Devices
- Rotational Thrombectomy Devices
- Others (including Ultrasonic Thrombectomy Devices, Chemical Thrombectomy Devices)
- By End-User
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others (including Diagnostic Centers, Research Institutions)
- By Application
- Acute Ischemic Stroke
- Deep Vein Thrombosis
- Pulmonary Embolism
- Peripheral Artery Disease
- Others (including Coronary Artery Disease, Renal Artery Thrombosis)
- By Technology
- Mechanical Thrombectomy
- Aspiration Thrombectomy
- Combination Thrombectomy
- Ultrasonic Thrombectomy
- Others (including Chemical Thrombectomy, Radiation-based Thrombectomy)
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Frequently Asked Questions
The current market size of the Thrombectomy Devices industry is estimated at US$ 1,527.9 million in 2023.
The key factors contributing significantly to the growth of the Thrombectomy Devices market include the increasing incidence of stroke and other vascular disorders, advancements in thrombectomy device technology, growing awareness about the benefits of minimally invasive procedures, and rising demand for effective and time-sensitive clot removal treatments.
The key factors hampering the growth of the Thrombectomy Devices Market include the high cost of thrombectomy devices and procedures, lack of skilled and trained healthcare professionals, reimbursement challenges in certain regions, and complications associated with thrombectomy procedures.
The leading component segment in the Thrombectomy Devices Market is the Mechanical Thrombectomy Devices, which offer improved precision and efficiency in clot removal compared to traditional treatments.
The major players operating in the Thrombectomy Devices Market include Medtronic plc, Stryker Corporation, Johnson & Johnson, Penumbra, Inc., Boston Scientific Corporation, Terumo Corporation, and others.
The Thrombectomy Devices Market is expected to grow at a CAGR of 7.4% from 2024 to 2031, reaching a market size of US$ 2,704.8 million by 2031.
The key drivers of the Thrombectomy Devices Market include the increasing incidence of stroke and other vascular disorders, advancements in thrombectomy device technology, growing awareness about the benefits of minimally invasive procedures, rising demand for effective and time-sensitive clot removal treatments, and the expansion of thrombectomy device applications beyond stroke.